Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY crawled date : 2021 - 05 - 11 save search
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
Published: 2021-05-11 (Crawled : 21:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.46%
H: 0.95%
C: 0.12%
CLLS | $2.48 0.81% 0.4% 15K
|
Health Technology
|
| O: 0.94%
H: 1.8%
C: -4.67%
car-t
Global Connected / Smart Drug Delivery Systems Market Report 2021: Current Landscape and Future Outlook for Devices Already Commercialized or Under Development
Published: 2021-05-11 (Crawled : 15:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
drug device drug delivery liver
AUM Biosciences enters in a Strategic Collaboration with Handok and CMG Pharm to develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment
Published: 2021-05-11 (Crawled : 14:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
treatment collaboration cancer
Cyclo Therapeutics Appoints Lori McKenna Gorski as Global Head of Patient Advocacy
Published: 2021-05-11 (Crawled : 13:15) - ir.stockpr.com
CYTH | $1.22 0.83% 0.82% 30K
|
Professional, Scientific, and T...
|
| O: -5.07%
H: 3.23%
C: 2.53%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
Global Bispecific Antibody Market Report 2021-2028: $18 Billion Opportunity, Drug Sales, Prices - 400+ Antibodies in Clinical Trials & 2 Commercially Available Bispecific Antibodies
Published: 2021-05-11 (Crawled : 12:00) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
sales clinical trials antibody drug trial
Aetion Closes $110M Series C Funding Round Led by Warburg Pincus
Published: 2021-05-11 (Crawled : 11:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.22%
H: 0.13%
C: -1.04%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
funding marburg
Evotec SE Reports Results for The First Quarter 2021 and Provides Corporate Update
Published: 2021-05-11 (Crawled : 09:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
results
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
Published: 2021-05-11 (Crawled : 07:00) - globenewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.45%
H: 0.98%
C: -0.83%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -7.78%
H: 8.52%
C: 6.11%
covid vaccine merge authorized covid-19
Innate Pharma First Quarter 2021 Report
Published: 2021-05-11 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.89%
H: 1.63%
C: 1.35%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.47%
H: 0.7%
C: 0.52%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: 4.66%
H: 1.49%
C: 1.49%
report pharma
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.